Kazuhiro Chiba
Corporate Officer/Principal at Tokyo University of Agriculture & Technology
Profile
Kazuhiro Chiba founded Jitsubo Co., Ltd.
in 2005, where he worked as Director & Chief Scientific Officer.
Dr. Chiba also currently works at Tokyo University of Agriculture & Technology, as Vice Dean & Professor.
Dr. Chiba also formerly worked at Kewpie Corp., as Principal.
Dr. Chiba received his graduate degree from Tokyo University of Agriculture & Technology.
Kazuhiro Chiba active positions
| Companies | Position | Start |
|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - |
Former positions of Kazuhiro Chiba
| Companies | Position | End |
|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Founder | - |
Training of Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Private companies | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Kazuhiro Chiba
